Rotigotine

Overview

Rotigotine is a non-ergoline, dopamine agonist used in the treatment of Parkinson’s disease and restless legs syndrome. It functions as a transdermal patch to deliver continuous stimulation to dopamine receptors.

API suppliers (2)

Suppliers of Rotigotine backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• Neuland Laboratories LimitedIndia1 active DMF
• OLON SPAItaly

Patent & exclusivity (US)

Per the FDA Orange Book (6 approved US products), the latest listed US patent on Rotigotine expires 1 Mar 2032. Generic API sourcing typically opens up once these lapse.

Therapeutic areas